243 related articles for article (PubMed ID: 9935208)
1. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo.
Rabbani SA; Gladu J; Harakidas P; Jamison B; Goltzman D
Int J Cancer; 1999 Jan; 80(2):257-64. PubMed ID: 9935208
[TBL] [Abstract][Full Text] [Related]
2. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
[TBL] [Abstract][Full Text] [Related]
3. Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer.
Shukeir N; Garde S; Wu JJ; Panchal C; Rabbani SA
Anticancer Drugs; 2005 Nov; 16(10):1045-51. PubMed ID: 16222145
[TBL] [Abstract][Full Text] [Related]
4. Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein.
Blomme EA; Dougherty KM; Pienta KJ; Capen CC; Rosol TJ; McCauley LK
Prostate; 1999 May; 39(3):187-97. PubMed ID: 10334108
[TBL] [Abstract][Full Text] [Related]
5. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
Shukeir N; Arakelian A; Chen G; Garde S; Ruiz M; Panchal C; Rabbani SA
Cancer Res; 2004 Aug; 64(15):5370-7. PubMed ID: 15289344
[TBL] [Abstract][Full Text] [Related]
6. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
Achbarou A; Kaiser S; Tremblay G; Ste-Marie LG; Brodt P; Goltzman D; Rabbani SA
Cancer Res; 1994 May; 54(9):2372-7. PubMed ID: 8162583
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
8. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
Rabbani SA; Harakidas P; Bowlin T; Attardo G
Cancer Res; 1998 Aug; 58(15):3461-5. PubMed ID: 9699681
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.
Park SI; McCauley LK
Endocr Relat Cancer; 2012 Jun; 19(3):243-54. PubMed ID: 22291434
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo.
Guise TA; Yin JJ; Thomas RJ; Dallas M; Cui Y; Gillespie MT
Bone; 2002 May; 30(5):670-6. PubMed ID: 11996903
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue.
Wu G; Iwamura M; di Sant'Agnese PA; Deftos LJ; Cockett AT; Gershagen S
Urology; 1998 May; 51(5A Suppl):110-20. PubMed ID: 9610565
[TBL] [Abstract][Full Text] [Related]
14. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
Kitazawa S; Kitazawa R
J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence that PTHrP expression promotes prostate cancer progression in bone.
Deftos LJ; Barken I; Burton DW; Hoffman RM; Geller J
Biochem Biophys Res Commun; 2005 Feb; 327(2):468-72. PubMed ID: 15629138
[TBL] [Abstract][Full Text] [Related]
16. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide.
Rabbani SA; Gladu J; Liu B; Goltzman D
Endocrinology; 1995 Dec; 136(12):5416-22. PubMed ID: 7588290
[TBL] [Abstract][Full Text] [Related]
17. Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions.
Liao J; Li X; Koh AJ; Berry JE; Thudi N; Rosol TJ; Pienta KJ; McCauley LK
Int J Cancer; 2008 Nov; 123(10):2267-78. PubMed ID: 18729185
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
19. EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
Bhatia V; Saini MK; Shen X; Bi LX; Qiu S; Weigel NL; Falzon M
Mol Cancer Ther; 2009 Jul; 8(7):1787-98. PubMed ID: 19584236
[TBL] [Abstract][Full Text] [Related]
20. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
